Special issue “Advances in Metabolomics for Precision Medicine: From Biomarker Discovery to Clinical Applications” focuses on the latest challenges and achievements in using metabolomics to diagnose diseases and monitor patients after treatment
, /PRNewswire/ — Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces the Multidisciplinary Digital Publishing Institute (MDPI) selects Metabolon scientists Dr. Adam Kennedy and Dr. Greg Michelotti to guest edit MDPI’s Metabolites journal.
The special issue, “Advances in Metabolomics for Precision Medicine: From Biomarker Discovery to Clinical Applications,” focuses on the latest challenges and achievements in metabolomics for diagnosing diseases and monitoring patients after treatment. This issue will include clinical studies and basic research using animal and cellular models to showcase recent developments in the field.
“Metabolomics places the functional output of the genome and the proteome into the hands of scientists and clinicians so …